FDA Approves Fitusiran as Prophylaxis of Bleeding Episodes Due to Hemophilia A or B
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
The Current, Future Roles of AI within the Pharmacy Profession
As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.
FDA Approves Gepotidacin for Uncomplicated UTI
The decision makes the therapy the first oral antibiotic treatment approved for uUTIs in over 20 years.
The Unique Challenges, Growth in the Business of Health-System Pharmacy
From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.
FDA Approves Vutrisiran For Adult Patients With ATTR-CM
The decision makes the RNAi therapeutic the only therapy approved by the FDA to treat ATTR-CM and hATTR-PN.
Q&A: What Role Will Pharmacists Play in Precision Medicine?
George Van Antwerp, MBA, discusses how the role of the pharmacist will evolve with the integration of precision medicine into the health systems setting.
